In early April the World Health Organization (WHO) announced that most provinces in Angola have experienced a yellow fever outbreak
. Now, scientists are calling this the country’s worst epidemic since 1986, urging WHO to take action.
The Threat of Yellow Fever
With a total of 2023 suspected cases and 258 deaths since it began in December 2015, Angola’s yellow fever outbreak is quickly spreading to other countries, including China, the Democratic Republic of Congo, and Kenya, as well as neighboring countries. In a recent article published
in the Journal of the American Medical Association
, study authors, Daniel Lucey, MD, MPH, and Lawrence O. Gostin, JD, state, “Similar to other recent epidemics, quick and effective action to stop the spread of yellow fever is the responsibility of the world’s health community.”
It was noted that a shortage in vaccines can result in a “health security crisis” if the virus spreads throughout Africa, Asia, and the Americas. The authors warn that in the Americas, where Aedes
mosquito populations are high, yellow fever can spread as quickly as Zika, Dengue, and Chikungunya. Furthermore, Asia has never before experienced a yellow fever epidemic and may not be well-equipped to handle an outbreak.
On April 22, the Pan American Health Organization declared an epidemiological alert for yellow fever in South America. The study authors warn that if WHO does not move forward with an emergency response plan that involves “a surge in vaccine production,” the current yellow fever outbreak can result in a global epidemic similar to that of the Ebola virus and the ongoing Zika crisis.
Yellow Fever Vaccine Shortage
A vaccine for yellow fever can provide lifetime protection against infection; however, individuals older than 60, infants, pregnant women, and those with severe immunodeficiencies or severe egg allergies, who do not live in or are not traveling to areas where the virus is widespread, should refrain from receiving vaccination.
Thus far, more than 7 million individuals have been vaccinated against yellow fever in Angola alone. Earlier in May, the Democratic Republic of Congo announced that 2 million individuals residing in Kinshasa and Kongo Central are to be vaccinated against yellow fever, since local viral transmission is expected to hit these areas.
Study authors urge WHO, which currently serves as the Secretariat for the International Coordinating Group (ICG) on Vaccine Provision for Yellow Fever, and its partners—the United Nations Children’s Fund (UNICEF), the International Federation of Red Cross and Red Crescent Societies, and Doctors without Borders—to take action to prevent a vaccine shortage. Although ICG preserves a vaccine supply in case of a global pandemic, the authors expect that a vaccine shortage is inevitable if the virus spreads to other countries and regions of the world. They note that, “surge capacity is currently limited because specific pathogen-free chicken eggs are needed to produce the vaccine.”